RxDoctor Payments Data

Xiaoping He, MD

Gastroenterology · Clive, IANPI 1922487941

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 94.3% of the total across 29 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 15 manufacturers, the largest accounting for just 23.2% — the pattern of someone who eats at a lot of different presentations.

$817in general payments, 2019–2025

Across 29 payments — averaging $28.17 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • AbbVie$190
  • Medtronic$139
  • Madrigal Pharmaceuticals$133
  • Johnson & Johnson$74
  • Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$67
  • Merck$38
  • plus $175 from 9 others

What the payments were for

  • Food & beverage$77094%
  • Education$476%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$817 in reported general payments places this provider in the 55th percentile of 113 gastroenterology providers in Iowa.

See all gastroenterology providers in Iowa

Medicare billing

Part B allowed, 2024
$57,496
Medicare patients
272
Services billed
456

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Mesalamine12$5,518
Sod Sulf-Potass Sulf-Mag SulfSodium, Potassium,mag Sulfates77$4,806
Peg 3350-ElectrolyteSodium Chloride/Nahco3/Kcl/Peg207$3,922
Dexlansoprazole DrDexlansoprazole22$3,833
Ursodiol15$1,813
CholestyramineCholestyramine (With Sugar)32$1,767
Omeprazole87$1,079
Pantoprazole Sodium111$770
Azathioprine16$672
Gavilyte-NSodium Chloride/Nahco3/Kcl/Peg46$593
Esomeprazole Magnesium16$548
Famotidine39$295
Ondansetron OdtOndansetron94$259
Spironolactone15$250
Ondansetron Hcl99$146

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Clive

See the full list for Iowa

Where these figures come from

Is this you, or does something look wrong? →